Objective: Use of real-time continuous glucose monitoring (rtCGM) has been shown to improve glycemic control in patients with type 2 diabetes (T2D) who are treated with intensive insulin therapy. However, most T2D patients are denied coverage for rtCGM due to failure to meet payer eligibility requirements: treatment with ≥3 insulin injections (or pump) and history of 4 × /day blood glucose testing. We investigated the relevance of these criteria to successful rtCGM use.

中文翻译：

---

使用实时连续血糖监测可改善接受较低强度治疗的 2 型糖尿病患者的血糖控制和其他临床结果

目的：使用实时连续血糖监测 (rtCGM) 已被证明可以改善接受强化胰岛素治疗的 2 型糖尿病 (T2D) 患者的血糖控制。然而，大多数 T2D 患者由于未能满足付款人资格要求而被拒绝承保 rtCGM：接受≥3 次胰岛素注射（或泵）的治疗以及 4 次/天血糖检测的历史。我们调查了这些标准与成功使用 rtCGM 的相关性。